De sero- positive rater for anti- HAV var 99, 0% og de sero- positive rater for anti - HBs var 99, 0% i måned 13 med sero- beskyttende rater på 97, 0%.
In a clinical study, 102 subjects aged from 12 years up to and including 15 years received the second dose of Ambirix at month 12, seropositivity rates for anti-HAV were 99.0% and seropositivity rates for anti-HBs were 99.0% at month 13 with seroprotection rates of 97.0%.